Research Oracle roundup for 02 December 2009
New Valuations
Embotelladora Andina S.A. (NYSE:AKOb) Although we expect Chilean and Brazilian operations to register a y-o-y decline in revenues in FY 2009 due to poor performance in 1H 09, we expect these operations to register y-o-y growth in FY 2010 driven by an increase in volumes and Average Selling Price (ASP). The company has launched several new products such as Fanta Uva, Aquarius, Sucos del Valle and the Crystal mineral in Chile and Brazil which we believe will diversify the company's product lines and boost top-line. However, we expect the Chilean and Brazilian operations will register a decline in operating margin in FY 2009 due to an anticipated increase in marketing expenses due to the launch of new products and increase in sugar prices. Nevertheless, we expect Chilean and Brazilian operations to register expansion in operating margin in FY 2010 due to the anticipated positive impact of new product launches on topline and increased prices. Furthermore, we expect Argentine operations to register y-o-y growth in FY 2010 revenues, driven by increased volumes and ASP. However, we expect operating margin to decline over the next two years due to increased marketing expenses and increased labor costs.
From September 2009, the Research Oracle will begin to accept research submissions from readers – whether amateur or professional analysts – from around the globe. To receive notification of the launch and rules, contributors may register now at
http://www.iirgroup.com/researchoracle/researchoracleaward
Read the full reports free of charge with free to view access to institutional-quality research on 400 companies and over 700 stocks at www.researchoracle.com
Important information for US investors.
With the ending of the Spitzer settlement in July 2009 there will be a dramatic reduction of free independent research available to investors like yourself. Although this will not impact the Research Oracle, we believe that freely available independent research is crucial for a healthy market to function. Ask your broker a/e what plans they expect to implement to continue to provide you with independent research. You may wish to read this recent coverage from TIME Magazine for more information.
Copyright © 2009 Independent International Investment Research PLC. All rights reserved.
http://www.time.com/time/business/article/0,8599,1893519,00.html


